selenomethylselenocysteine has been researched along with Experimental Hepatoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Fan, B; Huang, C; Li, J; Li, Y; Qi, C; Zhang, J; Zhang, Y | 1 |
1 other study(ies) available for selenomethylselenocysteine and Experimental Hepatoma
| Article | Year |
|---|---|
Se-Methylselenocysteine Alleviates Liver Injury in Diethylnitrosamine (DEN)-Induced Hepatocellular Carcinoma Rat Model by Reducing Liver Enzymes, Inhibiting Angiogenesis, and Suppressing Nitric Oxide (NO)/Nitric Oxide Synthase (NOS) Signaling Pathway.
Topics: Alanine Transaminase; Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Aspartate Aminotransferases; Carcinogenesis; Carcinoma, Hepatocellular; Cell Proliferation; Disease Models, Animal; gamma-Glutamyltransferase; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Nitric Oxide Synthase; Rats; Selenocysteine; Treatment Outcome | 2021 |